APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Esketamine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Esketamine Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchEsketamine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Esketamine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Esketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Esketamine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Esketamine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Esketamine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Esketamine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Esketamine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Esketamine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Esketamine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Esketamine include Janssen Pharmaceutica, Merck, PFIZER, Medkoo and Endo International, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Esketamine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Esketamine, also provides the sales of main regions and countries. Of the upcoming market potential for Esketamine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Esketamine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Esketamine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Esketamine sales, projected growth trends, production technology, application and end-user industry.

Esketamine Segment by Company

Janssen Pharmaceutica

Merck

PFIZER

Medkoo

Endo International

Esketamine Segment by Type

Injection

Oral Medications

Nasal Spray

Esketamine Segment by Application

General Anesthetic

Treatment-resistant Depression

Esketamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esketamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esketamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esketamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Esketamine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Esketamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Esketamine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Esketamine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Oral Medications Major Manufacturers Table 4. Nasal Spray Major Manufacturers Table 5. Global Esketamine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. General Anesthetic Major Manufacturers Table 7. Treatment-resistant Depression Major Manufacturers Table 8. Esketamine Industry Trends Table 9. Esketamine Industry Drivers Table 10. Esketamine Industry Opportunities and Challenges Table 11. Esketamine Industry Restraints Table 12. Global Esketamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Esketamine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Esketamine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Esketamine Revenue Market Share by Region (2021-2026) Table 16. Global Esketamine Revenue Market Share by Region (2027-2032) Table 17. Global Esketamine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Esketamine Sales by Region (2021-2026) & (k units) Table 19. Global Esketamine Sales by Region (2027-2032) & (k units) Table 20. Global Esketamine Sales Market Share by Region (2021-2026) Table 21. Global Esketamine Sales Market Share by Region (2027-2032) Table 22. Global Esketamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Esketamine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Esketamine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Esketamine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Esketamine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Esketamine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Esketamine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Esketamine Manufacturers, Product Type & Application Table 30. Global Esketamine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Esketamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Esketamine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Esketamine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Esketamine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Esketamine Revenue Market Share by Type (2021-2026) Table 37. Global Esketamine Revenue Market Share by Type (2027-2032) Table 38. Global Esketamine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Esketamine Sales by Type (2021-2026) & (k units) Table 40. Global Esketamine Sales by Type (2027-2032) & (k units) Table 41. Global Esketamine Sales Market Share by Type (2021-2026) Table 42. Global Esketamine Sales Market Share by Type (2027-2032) Table 43. Global Esketamine Price by Type (2021-2026) & (US$/unit) Table 44. Global Esketamine Price by Type (2027-2032) & (US$/unit) Table 45. Global Esketamine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Esketamine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Esketamine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Esketamine Revenue Market Share by Application (2021-2026) Table 49. Global Esketamine Revenue Market Share by Application (2027-2032) Table 50. Global Esketamine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Esketamine Sales by Application (2021-2026) & (k units) Table 52. Global Esketamine Sales by Application (2027-2032) & (k units) Table 53. Global Esketamine Sales Market Share by Application (2021-2026) Table 54. Global Esketamine Sales Market Share by Application (2027-2032) Table 55. Global Esketamine Price by Application (2021-2026) & (US$/unit) Table 56. Global Esketamine Price by Application (2027-2032) & (US$/unit) Table 57. Janssen Pharmaceutica Company Information Table 58. Janssen Pharmaceutica Business Overview Table 59. Janssen Pharmaceutica Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Janssen Pharmaceutica Esketamine Product Portfolio Table 61. Janssen Pharmaceutica Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Merck Esketamine Product Portfolio Table 66. Merck Recent Development Table 67. PFIZER Company Information Table 68. PFIZER Business Overview Table 69. PFIZER Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. PFIZER Esketamine Product Portfolio Table 71. PFIZER Recent Development Table 72. Medkoo Company Information Table 73. Medkoo Business Overview Table 74. Medkoo Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Medkoo Esketamine Product Portfolio Table 76. Medkoo Recent Development Table 77. Endo International Company Information Table 78. Endo International Business Overview Table 79. Endo International Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Endo International Esketamine Product Portfolio Table 81. Endo International Recent Development Table 82. North America Esketamine Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Esketamine Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Esketamine Sales by Type (2021-2026) & (k units) Table 85. North America Esketamine Sales by Type (2027-2032) & (k units) Table 86. North America Esketamine Sales Price by Type (2021-2026) & (US$/unit) Table 87. North America Esketamine Sales Price by Type (2027-2032) & (US$/unit) Table 88. North America Esketamine Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Esketamine Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Esketamine Sales by Application (2021-2026) & (k units) Table 91. North America Esketamine Sales by Application (2027-2032) & (k units) Table 92. North America Esketamine Sales Price by Application (2021-2026) & (US$/unit) Table 93. North America Esketamine Sales Price by Application (2027-2032) & (US$/unit) Table 94. North America Esketamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Esketamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Esketamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Esketamine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 98. North America Esketamine Sales by Country (2021-2026) & (k units) Table 99. North America Esketamine Sales by Country (2027-2032) & (k units) Table 100. North America Esketamine Sales Price by Country (2021-2026) & (US$/unit) Table 101. North America Esketamine Sales Price by Country (2027-2032) & (US$/unit) Table 102. United States Esketamine Revenue (2021-2032) & (US$ Million) Table 103. Canada Esketamine Revenue (2021-2032) & (US$ Million) Table 104. Mexico Esketamine Revenue (2021-2032) & (US$ Million) Table 105. Europe Esketamine Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Esketamine Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Esketamine Sales by Type (2021-2026) & (k units) Table 108. Europe Esketamine Sales by Type (2027-2032) & (k units) Table 109. Europe Esketamine Sales Price by Type (2021-2026) & (US$/unit) Table 110. Europe Esketamine Sales Price by Type (2027-2032) & (US$/unit) Table 111. Europe Esketamine Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Esketamine Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Esketamine Sales by Application (2021-2026) & (k units) Table 114. Europe Esketamine Sales by Application (2027-2032) & (k units) Table 115. Europe Esketamine Sales Price by Application (2021-2026) & (US$/unit) Table 116. Europe Esketamine Sales Price by Application (2027-2032) & (US$/unit) Table 117. Europe Esketamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Esketamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Esketamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Esketamine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 121. Europe Esketamine Sales by Country (2021-2026) & (k units) Table 122. Europe Esketamine Sales by Country (2027-2032) & (k units) Table 123. Europe Esketamine Sales Price by Country (2021-2026) & (US$/unit) Table 124. Europe Esketamine Sales Price by Country (2027-2032) & (US$/unit) Table 125. Germany Esketamine Revenue (2021-2032) & (US$ Million) Table 126. France Esketamine Revenue (2021-2032) & (US$ Million) Table 127. U.K. Esketamine Revenue (2021-2032) & (US$ Million) Table 128. Italy Esketamine Revenue (2021-2032) & (US$ Million) Table 129. Russia Esketamine Revenue (2021-2032) & (US$ Million) Table 130. Spain Esketamine Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Esketamine Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Esketamine Revenue (2021-2032) & (US$ Million) Table 133. Sweden Esketamine Revenue (2021-2032) & (US$ Million) Table 134. Poland Esketamine Revenue (2021-2032) & (US$ Million) Table 135. China Esketamine Revenue by Type (2021-2026) & (US$ Million) Table 136. China Esketamine Revenue by Type (2027-2032) & (US$ Million) Table 137. China Esketamine Sales by Type (2021-2026) & (k units) Table 138. China Esketamine Sales by Type (2027-2032) & (k units) Table 139. China Esketamine Sales Price by Type (2021-2026) & (US$/unit) Table 140. China Esketamine Sales Price by Type (2027-2032) & (US$/unit) Table 141. China Esketamine Revenue by Application (2021-2026) & (US$ Million) Table 142. China Esketamine Revenue by Application (2027-2032) & (US$ Million) Table 143. China Esketamine Sales by Application (2021-2026) & (k units) Table 144. China Esketamine Sales by Application (2027-2032) & (k units) Table 145. China Esketamine Sales Price by Application (2021-2026) & (US$/unit) Table 146. China Esketamine Sales Price by Application (2027-2032) & (US$/unit) Table 147. Asia Esketamine Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Esketamine Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Esketamine Sales by Type (2021-2026) & (k units) Table 150. Asia Esketamine Sales by Type (2027-2032) & (k units) Table 151. Asia Esketamine Sales Price by Type (2021-2026) & (US$/unit) Table 152. Asia Esketamine Sales Price by Type (2027-2032) & (US$/unit) Table 153. Asia Esketamine Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Esketamine Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Esketamine Sales by Application (2021-2026) & (k units) Table 156. Asia Esketamine Sales by Application (2027-2032) & (k units) Table 157. Asia Esketamine Sales Price by Application (2021-2026) & (US$/unit) Table 158. Asia Esketamine Sales Price by Application (2027-2032) & (US$/unit) Table 159. Asia Esketamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Esketamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Esketamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Esketamine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. Asia Esketamine Sales by Country (2021-2026) & (k units) Table 164. Asia Esketamine Sales by Country (2027-2032) & (k units) Table 165. Asia Esketamine Sales Price by Country (2021-2026) & (US$/unit) Table 166. Asia Esketamine Sales Price by Country (2027-2032) & (US$/unit) Table 167. Japan Esketamine Revenue (2021-2032) & (US$ Million) Table 168. South Korea Esketamine Revenue (2021-2032) & (US$ Million) Table 169. India Esketamine Revenue (2021-2032) & (US$ Million) Table 170. Australia Esketamine Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Esketamine Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Esketamine Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Esketamine Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Esketamine Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Esketamine Sales by Type (2021-2026) & (k units) Table 176. SAMEA Esketamine Sales by Type (2027-2032) & (k units) Table 177. SAMEA Esketamine Sales Price by Type (2021-2026) & (US$/unit) Table 178. SAMEA Esketamine Sales Price by Type (2027-2032) & (US$/unit) Table 179. SAMEA Esketamine Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Esketamine Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Esketamine Sales by Application (2021-2026) & (k units) Table 182. SAMEA Esketamine Sales by Application (2027-2032) & (k units) Table 183. SAMEA Esketamine Sales Price by Application (2021-2026) & (US$/unit) Table 184. SAMEA Esketamine Sales Price by Application (2027-2032) & (US$/unit) Table 185. SAMEA Esketamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Esketamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Esketamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Esketamine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. SAMEA Esketamine Sales by Country (2021-2026) & (k units) Table 190. SAMEA Esketamine Sales by Country (2027-2032) & (k units) Table 191. SAMEA Esketamine Sales Price by Country (2021-2026) & (US$/unit) Table 192. SAMEA Esketamine Sales Price by Country (2027-2032) & (US$/unit) Table 193. Brazil Esketamine Revenue (2021-2032) & (US$ Million) Table 194. Argentina Esketamine Revenue (2021-2032) & (US$ Million) Table 195. Chile Esketamine Revenue (2021-2032) & (US$ Million) Table 196. Colombia Esketamine Revenue (2021-2032) & (US$ Million) Table 197. Peru Esketamine Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Esketamine Revenue (2021-2032) & (US$ Million) Table 199. Israel Esketamine Revenue (2021-2032) & (US$ Million) Table 200. UAE Esketamine Revenue (2021-2032) & (US$ Million) Table 201. Turkey Esketamine Revenue (2021-2032) & (US$ Million) Table 202. Iran Esketamine Revenue (2021-2032) & (US$ Million) Table 203. Egypt Esketamine Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Esketamine Distributors List Table 207. Esketamine Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Esketamine Image Figure 2. Global Esketamine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esketamine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Oral Medications Image Figure 6. Nasal Spray Image Figure 7. Global Esketamine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Esketamine Market Size Share 2021 VS 2025 VS 2032 Figure 9. General Anesthetic Image Figure 10. Treatment-resistant Depression Image Figure 11. Global Esketamine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Esketamine Revenue (2021-2032) & (US$ Million) Figure 13. Global Esketamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Esketamine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Esketamine Revenue Market Share by Region (2021-2032) Figure 16. Global Esketamine Sales (2021-2032) & (k units) Figure 17. Global Esketamine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Esketamine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Esketamine Sales YoY (2021-2032) & (k units) Figure 20. Europe Esketamine Sales YoY (2021-2032) & (k units) Figure 21. China Esketamine Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Esketamine Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Esketamine Sales YoY (2021-2032) & (k units) Figure 24. Global Esketamine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Esketamine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Esketamine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Esketamine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Esketamine Revenue Market Share by Type (2021-2032) Figure 30. Global Esketamine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Esketamine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Esketamine Sales Market Share by Type (2021-2032) Figure 33. Global Esketamine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Esketamine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Esketamine Revenue Market Share by Application (2021-2032) Figure 36. Global Esketamine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Esketamine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Esketamine Sales Market Share by Application (2021-2032) Figure 39. North America Esketamine Revenue Share by Type (2021-2032) Figure 40. North America Esketamine Sales Share by Type (2021-2032) Figure 41. North America Esketamine Revenue Share by Application (2021-2032) Figure 42. North America Esketamine Sales Share by Application (2021-2032) Figure 43. North America Esketamine Revenue Share by Country (2021-2032) Figure 44. North America Esketamine Sales Share by Country (2021-2032) Figure 45. Europe Esketamine Revenue Share by Type (2021-2032) Figure 46. Europe Esketamine Sales Share by Type (2021-2032) Figure 47. Europe Esketamine Revenue Share by Application (2021-2032) Figure 48. Europe Esketamine Sales Share by Application (2021-2032) Figure 49. Europe Esketamine Revenue Share by Country (2021-2032) Figure 50. Europe Esketamine Sales Share by Country (2021-2032) Figure 51. China Esketamine Revenue Share by Type (2021-2032) Figure 52. China Esketamine Sales Share by Type (2021-2032) Figure 53. China Esketamine Revenue Share by Application (2021-2032) Figure 54. China Esketamine Sales Share by Application (2021-2032) Figure 55. Asia Esketamine Revenue Share by Type (2021-2032) Figure 56. Asia Esketamine Sales Share by Type (2021-2032) Figure 57. Asia Esketamine Revenue Share by Application (2021-2032) Figure 58. Asia Esketamine Sales Share by Application (2021-2032) Figure 59. Asia Esketamine Revenue Share by Country (2021-2032) Figure 60. Asia Esketamine Sales Share by Country (2021-2032) Figure 61. SAMEA Esketamine Revenue Share by Type (2021-2032) Figure 62. SAMEA Esketamine Sales Share by Type (2021-2032) Figure 63. SAMEA Esketamine Revenue Share by Application (2021-2032) Figure 64. SAMEA Esketamine Sales Share by Application (2021-2032) Figure 65. SAMEA Esketamine Revenue Share by Country (2021-2032) Figure 66. SAMEA Esketamine Sales Share by Country (2021-2032) Figure 67. Esketamine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Esketamine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral Medications
  • Nasal Spray
Applications
  • General Anesthetic
  • Treatment-resistant Depression
Companies covered
  • Janssen Pharmaceutica
  • Merck
  • PFIZER
  • Medkoo
  • Endo International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Esketamine Market by Type
  3. 1.2.1 Global Esketamine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Oral Medications
  6. 1.2.4 Nasal Spray
  7. 1.3 Esketamine Market by Application
  8. 1.3.1 Global Esketamine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 General Anesthetic
  10. 1.3.3 Treatment-resistant Depression
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Esketamine Market Dynamics
  1. 2.1 Esketamine Industry Trends
  2. 2.2 Esketamine Industry Drivers
  3. 2.3 Esketamine Industry Opportunities and Challenges
  4. 2.4 Esketamine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Esketamine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Esketamine Revenue by Region
  3. 3.2.1 Global Esketamine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Esketamine Revenue by Region (2021-2026)
  5. 3.2.3 Global Esketamine Revenue by Region (2027-2032)
  6. 3.2.4 Global Esketamine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Esketamine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Esketamine Sales by Region
  9. 3.4.1 Global Esketamine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Esketamine Sales by Region (2021-2026)
  11. 3.4.3 Global Esketamine Sales by Region (2027-2032)
  12. 3.4.4 Global Esketamine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Esketamine Revenue by Manufacturers
  2. 4.1.1 Global Esketamine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Esketamine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Esketamine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Esketamine Sales by Manufacturers
  6. 4.2.1 Global Esketamine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Esketamine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Esketamine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Esketamine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Esketamine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Esketamine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Esketamine Manufacturers, Product Type & Application
  13. 4.7 Global Esketamine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Esketamine Market CR5 and HHI
  16. 4.8.2 2025 Esketamine Tier 1, Tier 2, and Tier 3
5 Esketamine Market by Type
  1. 5.1 Global Esketamine Revenue by Type
  2. 5.1.1 Global Esketamine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Esketamine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Esketamine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Esketamine Sales by Type
  6. 5.2.1 Global Esketamine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Esketamine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Esketamine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Esketamine Price by Type
6 Esketamine Market by Application
  1. 6.1 Global Esketamine Revenue by Application
  2. 6.1.1 Global Esketamine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Esketamine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Esketamine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Esketamine Sales by Application
  6. 6.2.1 Global Esketamine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Esketamine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Esketamine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Esketamine Price by Application
7 Company Profiles
  1. 7.1 Janssen Pharmaceutica
  2. 7.1.1 Janssen Pharmaceutica Company Information
  3. 7.1.2 Janssen Pharmaceutica Business Overview
  4. 7.1.3 Janssen Pharmaceutica Esketamine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Pharmaceutica Esketamine Product Portfolio
  6. 7.1.5 Janssen Pharmaceutica Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Esketamine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Esketamine Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 PFIZER
  14. 7.3.1 PFIZER Company Information
  15. 7.3.2 PFIZER Business Overview
  16. 7.3.3 PFIZER Esketamine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 PFIZER Esketamine Product Portfolio
  18. 7.3.5 PFIZER Recent Developments
  19. 7.4 Medkoo
  20. 7.4.1 Medkoo Company Information
  21. 7.4.2 Medkoo Business Overview
  22. 7.4.3 Medkoo Esketamine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Medkoo Esketamine Product Portfolio
  24. 7.4.5 Medkoo Recent Developments
  25. 7.5 Endo International
  26. 7.5.1 Endo International Company Information
  27. 7.5.2 Endo International Business Overview
  28. 7.5.3 Endo International Esketamine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Endo International Esketamine Product Portfolio
  30. 7.5.5 Endo International Recent Developments
8 North America
  1. 8.1 North America Esketamine Market Size by Type
  2. 8.1.1 North America Esketamine Revenue by Type (2021-2032)
  3. 8.1.2 North America Esketamine Sales by Type (2021-2032)
  4. 8.1.3 North America Esketamine Price by Type (2021-2032)
  5. 8.2 North America Esketamine Market Size by Application
  6. 8.2.1 North America Esketamine Revenue by Application (2021-2032)
  7. 8.2.2 North America Esketamine Sales by Application (2021-2032)
  8. 8.2.3 North America Esketamine Price by Application (2021-2032)
  9. 8.3 North America Esketamine Market Size by Country
  10. 8.3.1 North America Esketamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Esketamine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Esketamine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Esketamine Market Size by Type
  2. 9.1.1 Europe Esketamine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Esketamine Sales by Type (2021-2032)
  4. 9.1.3 Europe Esketamine Price by Type (2021-2032)
  5. 9.2 Europe Esketamine Market Size by Application
  6. 9.2.1 Europe Esketamine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Esketamine Sales by Application (2021-2032)
  8. 9.2.3 Europe Esketamine Price by Application (2021-2032)
  9. 9.3 Europe Esketamine Market Size by Country
  10. 9.3.1 Europe Esketamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Esketamine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Esketamine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Esketamine Market Size by Type
  2. 10.1.1 China Esketamine Revenue by Type (2021-2032)
  3. 10.1.2 China Esketamine Sales by Type (2021-2032)
  4. 10.1.3 China Esketamine Price by Type (2021-2032)
  5. 10.2 China Esketamine Market Size by Application
  6. 10.2.1 China Esketamine Revenue by Application (2021-2032)
  7. 10.2.2 China Esketamine Sales by Application (2021-2032)
  8. 10.2.3 China Esketamine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Esketamine Market Size by Type
  2. 11.1.1 Asia Esketamine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Esketamine Sales by Type (2021-2032)
  4. 11.1.3 Asia Esketamine Price by Type (2021-2032)
  5. 11.2 Asia Esketamine Market Size by Application
  6. 11.2.1 Asia Esketamine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Esketamine Sales by Application (2021-2032)
  8. 11.2.3 Asia Esketamine Price by Application (2021-2032)
  9. 11.3 Asia Esketamine Market Size by Country
  10. 11.3.1 Asia Esketamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Esketamine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Esketamine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Esketamine Market Size by Type
  2. 12.1.1 SAMEA Esketamine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Esketamine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Esketamine Price by Type (2021-2032)
  5. 12.2 SAMEA Esketamine Market Size by Application
  6. 12.2.1 SAMEA Esketamine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Esketamine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Esketamine Price by Application (2021-2032)
  9. 12.3 SAMEA Esketamine Market Size by Country
  10. 12.3.1 SAMEA Esketamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Esketamine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Esketamine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Esketamine Value Chain Analysis
  2. 13.1.1 Esketamine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Esketamine Production Mode & Process
  6. 13.2 Esketamine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Esketamine Distributors
  9. 13.2.3 Esketamine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst